Provider
QP96-20 Medical Drug Update for New to Market Inclisiran
Program effective Date: Oct 14, 2020
Documents & Forms Results
Displaying 1491 - 1500 of 3702 results
Provider
QP97-20 MHCP Pharmacy Benefit Update – New Drug-Related Prior Authorization (PA) with Quantity Limit (QL) Criteria: Hemophilia Factor VIII PA with QL
Program effective Date: Oct 14, 2020
Provider
QP98-20 MHCP Pharmacy Benefit Update – New Drug-Related Prior Authorization (PA) with Quantity Limit (QL) Criteria: Fintepla® (fenfluramine) PA with QL
Program effective Date: Oct 14, 2020
Provider
QP101-20 MHCP Pharmacy Benefit Update – New Drug-Related Prior Authorization (PA) Criteria: Dojolvi™ PA
Program effective Date: Oct 14, 2020
Provider
QP100-20 MHCP Pharmacy Benefit Update – New Drug-Related Prior Authorization (PA) with Quantity Limit (QL) Criteria: Hemophilia Factor IX PA with QL
Program effective Date: Oct 14, 2020
Provider
QP95-20 Commercial Pharmacy Benefit Exclusion for Jelmyto®
Program effective Date: Oct 14, 2020
Provider
QP94-20 Commercial Pharmacy Benefit Exclusion for Condylox®, Lyumjev™, Veregen® and Zilxi™
Program effective Date: Oct 14, 2020
Provider
QP102-20 Introducing eviCore’s new intelliPath® Technology
Program effective Date: Oct 14, 2020